Literature DB >> 32112532

Antithrombin: An anticoagulant, anti-inflammatory and antibacterial serpin.

Alireza R Rezaie1,2, Hemant Giri1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32112532      PMCID： PMC7080319          DOI： 10.1111/jth.14724

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  44 in total

1.  Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli.

Authors:  M C Minnema; A C Chang; P M Jansen; Y T Lubbers; B M Pratt; B G Whittaker; F B Taylor; C E Hack; B Friedman
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

2.  Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin.

Authors:  N Harada; K Okajima; S Kushimoto; H Isobe; K Tanaka
Journal:  Blood       Date:  1999-01-01       Impact factor: 22.113

3.  Antimicrobial effects of helix D-derived peptides of human antithrombin III.

Authors:  Praveen Papareddy; Martina Kalle; Ravi K V Bhongir; Matthias Mörgelin; Martin Malmsten; Artur Schmidtchen
Journal:  J Biol Chem       Date:  2014-09-08       Impact factor: 5.157

Review 4.  Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors.

Authors:  Steven T Olson; Benjamin Richard; Gonzalo Izaguirre; Sophia Schedin-Weiss; Peter G W Gettins
Journal:  Biochimie       Date:  2010-06-02       Impact factor: 4.079

5.  Antithrombin up-regulates AMP-activated protein kinase signalling during myocardial ischaemia/reperfusion injury.

Authors:  Yina Ma; Jinli Wang; Junjie Gao; Hui Yang; Yanqing Wang; Chandrashekhara Manithody; Ji Li; Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2014-09-18       Impact factor: 5.249

6.  Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.

Authors:  S T Olson; I Björk; R Sheffer; P A Craig; J D Shore; J Choay
Journal:  J Biol Chem       Date:  1992-06-25       Impact factor: 5.157

7.  High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety.

Authors:  Christian J Wiedermann; Johannes N Hoffmann; Mathias Juers; Helmut Ostermann; Joachim Kienast; Josef Briegel; Richard Strauss; Heinz-Otto Keinecke; Brian L Warren; Steven M Opal
Journal:  Crit Care Med       Date:  2006-02       Impact factor: 7.598

8.  Partial glycosylation of antithrombin III asparagine-135 is caused by the serine in the third position of its N-glycosylation consensus sequence and is responsible for production of the beta-antithrombin III isoform with enhanced heparin affinity.

Authors:  V Picard; E Ersdal-Badju; S C Bock
Journal:  Biochemistry       Date:  1995-07-04       Impact factor: 3.162

9.  Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa.

Authors:  A Danielsson; E Raub; U Lindahl; I Björk
Journal:  J Biol Chem       Date:  1986-11-25       Impact factor: 5.157

10.  Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.

Authors:  T Tagami; H Matsui; H Horiguchi; K Fushimi; H Yasunaga
Journal:  J Thromb Haemost       Date:  2014-07-16       Impact factor: 5.824
View more
  5 in total

1.  Murine Models in the Evaluation of Heparan Sulfate-Based Anticoagulants.

Authors:  Bassem M Mohammed; Qiufang Cheng; Ivan S Ivanov; David Gailani
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research.

Authors:  Behnood Bikdeli; Mahesh V Madhavan; Aakriti Gupta; David Jimenez; John R Burton; Caroline Der Nigoghossian; Taylor Chuich; Shayan Nabavi Nouri; Isaac Dreyfus; Elissa Driggin; Sanjum Sethi; Kartik Sehgal; Saurav Chatterjee; Walter Ageno; Mohammad Madjid; Yutao Guo; Liang V Tang; Yu Hu; Laurent Bertoletti; Jay Giri; Mary Cushman; Isabelle Quéré; Evangelos P Dimakakos; C Michael Gibson; Giuseppe Lippi; Emmanuel J Favaloro; Jawed Fareed; Alfonso J Tafur; Dominic P Francese; Jaya Batra; Anna Falanga; Kevin J Clerkin; Nir Uriel; Ajay Kirtane; Claire McLintock; Beverley J Hunt; Alex C Spyropoulos; Geoffrey D Barnes; John W Eikelboom; Ido Weinberg; Sam Schulman; Marc Carrier; Gregory Piazza; Joshua A Beckman; Martin B Leon; Gregg W Stone; Stephan Rosenkranz; Samuel Z Goldhaber; Sahil A Parikh; Manuel Monreal; Harlan M Krumholz; Stavros V Konstantinides; Jeffrey I Weitz; Gregory Y H Lip
Journal:  Thromb Haemost       Date:  2020-05-30       Impact factor: 5.249

Review 3.  Antithrombin and Its Role in Host Defense and Inflammation.

Authors:  Christine Schlömmer; Anna Brandtner; Mirjam Bachler
Journal:  Int J Mol Sci       Date:  2021-04-20       Impact factor: 5.923

4.  Antithrombin activity levels for predicting long-term outcomes in the early phase of isolated traumatic brain injury.

Authors:  Masaki Takahashi; Takeshi Wada; Ryuta Nakae; Yu Fujiki; Takahiro Kanaya; Yasuhiro Takayama; Go Suzuki; Yasutaka Naoe; Shoji Yokobori
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

Review 5.  Anticoagulant and signaling functions of antithrombin.

Authors:  Alireza R Rezaie; Hemant Giri
Journal:  J Thromb Haemost       Date:  2020-09-09       Impact factor: 16.036
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.